SPARCNSESun Pharma Advanced Research Company Limited· PharmaceuticalsMinimalNeutral
Announced Mon, 6 Jul · 11:55 IST

Routine compliance filing regarding dematerialisation of securities for Q1FY27

SPARC · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+10.7%1-day move
₹239.10
prior close
₹254.60
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.0-0.2-0.1+1.5+10.7+13.0+16.3+10.7+8.6+5.4-10.1
Up moveDown movePending
AI summary

SPARC filed a routine compliance certificate under SEBI's Depositories Regulations for the quarter ended June 30, 2026. The certificate, issued by its registrar MUFG Intime India, confirms that shares received for dematerialisation during the quarter were processed, listed on stock exchanges, and the register of members was updated within prescribed timelines. This is a standard procedural filing with no business or financial impact.

Likely market impact

No material impact; routine regulatory compliance filing required under SEBI rules.